Signature-Logo.png
Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
22 août 2023 08h05 HE | Trxade Health, Inc.
Combined company, focused on sustainable, equitable food portfolio, expected to more readily penetrate new markets and accelerate transition to animal-free brands Once complete, transaction...
Signature-Logo.png
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14 août 2023 10h25 HE | Trxade Health, Inc.
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file...
Signature-Logo.png
Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
03 août 2023 09h05 HE | Trxade Health, Inc.
Forbes Fisher Appointed as Chief Operating Officer.Dr. Eugenio Bortone Appointed as Chief Innovation & Food Technology Officer. TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH,...
Signature-Logo.png
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
31 juil. 2023 08h35 HE | Trxade Health, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced...
Signature-Logo.png
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
14 juil. 2023 16h30 HE | Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...
Trxade_Corp_Logo.jpg
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
21 juin 2023 12h36 HE | Trxade Health, Inc.
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its...
Trxade_Corp_Logo.jpg
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
15 mai 2023 16h15 HE | Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
Trxade_Corp_Logo.jpg
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
07 nov. 2022 16h30 HE | Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the...
Trxade_Corp_Logo.jpg
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups
25 oct. 2022 08h30 HE | Trxade Health, Inc.
TAMPA, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare platform, today announced that...
Trxade_Corp_Logo.jpg
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
03 oct. 2022 09h15 HE | Trxade Health, Inc.
TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by...